Results 171 to 180 of about 55,098,274 (381)
Circulating tumor cells: advancing personalized therapy in small cell lung cancer patients
Molecular Oncology, EarlyView.Small cell lung cancer (SCLC) is an aggressive form of lung cancer that spreads rapidly to secondary sites such as the brain and liver. Cancer cells circulating in the blood, “circulating tumor cells” (CTCs), have demonstrated prognostic value in SCLC, and evaluating biomarkers on CTCs could guide treatment decisions such as for PARP inhibitors ...
Prajwol Shrestha +6 more
wiley +1 more source
THE EFFECTS OF VERTICAL VORTICITY ADVECTION AND TURNING OF THE VORTEX TUBES IN HEMISPHERIC FORECASTS WITH A TWO-LEVEL MODEL [PDF]
, 1959 Geirmundur Árnason, L. P. Carstensen
openalex +1 more source
Is the American model Miss World? Choosing between the Anglo-Saxon model and a European-style alternative [PDF]
In Lisbon, the European Union has set itself the goal to become the most competitive economy in the world in 2010 without harming social cohesion and the environment.
Henri de Groot +2 more
core
Cognitive Strategies of S²r Model Used by High Proficiency Learners of the English Department, Petra Christian University [PDF]
, 2017 This is a qualitative and quantitative study on cognitive strategies of S²R model and specific techniques employed by high proficient learners of the English Department, Petra Christian University.
Samalaty, M. S. (Mega) +1 more
core
A comparative study of circulating tumor cell isolation and enumeration technologies in lung cancer
Molecular Oncology, EarlyView.Lung cancer cells were spiked into donor blood to evaluate the recovery rates of the following circulating tumor cell (CTC) enrichment technologies: CellMag™, EasySep™, RosetteSep™, Parsortix® PR1, and Parsortix® Prototype systems. Each method's advantages and disadvantages are described.
Volga M Saini +11 more
wiley +1 more source
On the Anharmonic Pulsations of the Standard Model [PDF]
, 1949 C. Prasad, E. A. Milne
openalex +1 more source
Cell‐free and extracellular vesicle microRNAs with clinical utility for solid tumors
Molecular Oncology, EarlyView.Cell‐free microRNAs (cfmiRs) are small‐RNA circulating molecules detectable in almost all body biofluids. Innovative technologies have improved the application of cfmiRs to oncology, with a focus on clinical needs for different solid tumors, but with emphasis on diagnosis, prognosis, cancer recurrence, as well as treatment monitoring.
Yoshinori Hayashi +6 more
wiley +1 more source